Skip to main content

Celia Crane LaBranche, PhD

Publications

Tuyishime, Marina, Carolina Garrido, Shalini Jha, Matt Moeser, Dieter Mielke, Celia LaBranche, David Montefiori, et al. “Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies.” J Clin Invest 130, no. 10 (October 1, 2020): 5157–70. https://doi.org/10.1172/JCI135557.

Full Text

Wu, Fan, Ilnour Ourmanov, Andrea Kirmaier, Sivan Leviyang, Celia LaBranche, Jinghe Huang, Sonya Whitted, Kenta Matsuda, David Montefiori, and Vanessa M. Hirsch. “SIV infection duration largely determines broadening of neutralizing antibody response in macaques.” J Clin Invest 130, no. 10 (October 1, 2020): 5413–24. https://doi.org/10.1172/JCI139123.

Full Text

Korber, Bette, Will M. Fischer, Sandrasegaram Gnanakaran, Hyejin Yoon, James Theiler, Werner Abfalterer, Nick Hengartner, et al. “Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.” Cell 182, no. 4 (August 20, 2020): 812-827.e19. https://doi.org/10.1016/j.cell.2020.06.043.

Full Text

Shao, Shuai, Wei-Chiao Huang, Cuiyan Lin, Mark D. Hicar, Celia C. LaBranche, David C. Montefiori, and Jonathan F. Lovell. “An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice.” Ann Biomed Eng 48, no. 7 (July 2020): 1991–2001. https://doi.org/10.1007/s10439-019-02398-8.

Full Text

Lewis, Phoebe E., Ethan C. Poteet, Dongliang Liu, Changyi Chen, Celia C. LaBranche, Sherry A. Stanfield-Oakley, David C. Montefiori, Guido Ferrari, and Qizhi Yao. “CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses.” Vaccines (Basel) 8, no. 2 (June 6, 2020). https://doi.org/10.3390/vaccines8020284.

Full Text

Kasturi, Sudhir Pai, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, Mathew Pham, Traci Legere, Zarpheen Jinnah Sher, Yevgeny Kovalenkov, et al. “3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates.” Science Immunology 5, no. 48 (June 2020). https://doi.org/10.1126/sciimmunol.abb1025.

Full Text

Arunachalam, Prabhu S., Tysheena P. Charles, Vineet Joag, Venkata S. Bollimpelli, Madeleine K. D. Scott, Florian Wimmers, Samantha L. Burton, et al. “T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.” Nat Med 26, no. 6 (June 2020): 932–40. https://doi.org/10.1038/s41591-020-0858-8.

Full Text

Sun, Lina, Amy V. Paschall, Dustin R. Middleton, Mayumi Ishihara, Ahmet Ozdilek, Paeton L. Wantuch, Javid Aceil, et al. “Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help.” Nat Commun 11, no. 1 (May 21, 2020): 2550. https://doi.org/10.1038/s41467-020-16319-0.

Full Text

Felber, Barbara K., Zhongyan Lu, Xintao Hu, Antonio Valentin, Margherita Rosati, Christopher A. L. Remmel, Joshua A. Weiner, et al. “Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge.” Cell Reports 31, no. 6 (May 2020): 107624. https://doi.org/10.1016/j.celrep.2020.107624.

Full Text

Schifanella, Luca, Susan W. Barnett, Massimiliano Bissa, Veronica Galli, Melvin N. Doster, Monica Vaccari, Georgia D. Tomaras, et al. “Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.” Plos Pathogens 16, no. 4 (April 28, 2020): e1008531. https://doi.org/10.1371/journal.ppat.1008531.

Full Text

Pages